NEW YORK– Schrödinger, Inc. (the “Company”) (Nasdaq: SDGR), whose differentiated, physics-based software platform enables discovery of high-quality, novel molecules for drug development and materials applications, today announced the closing of its initial public offering of 13,664,704 shares of common stock at a public offering price of $17.00 per share, which includes 1,782,352 additional shares of […]
NEW YORK — Enzo Biochem, Inc. (NYSE:ENZ) (the “Company”) today disclosed that Harbert Discovery Fund, LP (“Harbert”) filed a lawsuit against the Company and the members of its board of directors (“Board”) in the U.S. District Court for the Southern District of New York. Enzo commented as follows: “We are disappointed but not surprised by […]
GenapSys’s highly accurate sequencer is poised to help researchers and public health officials across Asia better track and understand the outbreak Redwood City, Calif. — GenapSys Inc. announced today the launch of its gene sequencer in the Asia Pacific (APAC) region, including in Korea, Singapore, Japan, and the fast-growing Chinese gene sequencing market, which is […]
NEWARK, Calif. — Intabio, a developer of instrumentation systems for biotherapeutic precision analysis and quality assessment throughout bioproduction, today announced a Series B investment of $18 million. The financing round was led by Northpond Ventures, with additional funds coming from Genoa Ventures and Vertical Venture Partners. In a testament to Intabio’s steady progress, the step-up valuation […]
NEW YORK–Schrödinger, Inc. (the “Company”) (Nasdaq: SDGR), whose differentiated, physics-based software platform enables discovery of high-quality, novel molecules for drug development and materials applications, today announced the pricing of its initial public offering of 11,882,352 shares of common stock at a public offering price of $17.00 per share, for total gross proceeds of approximately $202.0 […]
ST. LOUIS, MO —Biotech company Adarza BioSystems announced today that it has raised $25 million in a Series D round co-led by 3×5 Partners, based in Portland, Ore., and St. Louis-based Lightchain Capital, LLC, the family office of Scottrade founder Rodger Riney. Adarza plans to use the funds to support full commercialization of ZIVA, its […]
TORONTO — BenchSci, which uses machine learning to identify and resolve preclinical research inefficiencies in drug discovery, announced today it has raised $22 million in Series B financing, launched its new AI-Assisted Reagent Selection product, and expanded its contract with Novartis in a market worth more than $10.2 billion per year in life science R&D cost-saving opportunities. F-Prime […]
Vizgen leverages validated, proprietary technology to push the boundaries of spatially resolved, single-cell transcriptomics, yielding unprecedented insight into molecular and cellular organization of both heathy and pathological tissues. CAMBRIDGE, Mass. — Vizgen, a privately-held biotech company developing solutions for next-generation spatially resolved, single-cell transcriptomics, announced the closing of a $14 million Series A financing led by ARCH Venture Partners […]
Enzo Biochem, Inc. (NYSE:ENZ) today commented on Harbert’s press release in reaction to Enzo’s announcement that it is providing its shareholders with additional choices: “We are surprised by Harbert’s public comments yesterday in reaction to our Tuesday announcement that we would welcome Harbert’s two nominees onto the Board and provide shareholders the choice to benefit […]
Assures the Election of Both Harbert Nominees Withdraws Nomination of Dr. Bruce Hanna, Ph.D.; Current Nominees Rebecca Fischer and Barry Weiner Remain Post Appointment of New Diverse Director, 71% of Directors Would be Independent; 80% of Independent Directors Would be New Additions Since Last Annual Meeting Company to Mail Proxy Supplement and New GOLD Proxy […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
